Group Members
![](https://primary.jwwb.nl/public/y/g/q/temp-wibtyspuysxvsaokmyjj/td4c07/Allott_Profile.jpg?enable-io=true&enable=upscale&crop=1920%2C1920%2Cx0%2Cy71%2Csafe&width=160&height=160)
Dr Louis Allott (Group Leader)
Lecturer in Radiochemistry & Molecular Imaging - Hull York Medical School
Head of Radiochemistry - Hull Molecular Imaging Centres
Louis completed his master’s degree in chemistry (MChem) at the University of Hull in 2011 and continued studying for a PhD in PET Radiochemistry (2011 – 2014). He started post-doctoral research in the Division of Radiotherapy and Imaging, Institute of Cancer Research (2014 – 2017) under the supervision of Dr Graham Smith; followed by a position with Prof Eric Aboagye in the Faculty of Medicine, Imperial College London as a Post-doctoral Research Associate and Chemistry Team Leader (2017 – 2020). In January 2021, Louis returned to the University of Hull as Lecturer in Translational Radiopharmaceutics where he joined the team to set up the new Molecular Imaging Research Centre and establish a new research group. His group develops small-molecule and biomolecule PET radiochemistry, advanced automated radiosynthesis protocols and novel radiopharmaceuticals for clinical translation
![](https://primary.jwwb.nl/public/y/g/q/temp-wibtyspuysxvsaokmyjj/gog6cu/unknown.jpeg?enable-io=true&enable=upscale&crop=712%2C712%2Cx8%2Cy0%2Csafe&width=146&height=146)
Joe Ercolano
PhD Student (2nd Year). Joe is working on novel radiochemistry and radiopharmaceuticals for PET imaging immune targets.
![](https://primary.jwwb.nl/public/y/g/q/temp-wibtyspuysxvsaokmyjj/e6l8i3/img-20230908-wa00212-1.jpg?enable-io=true&enable=upscale&crop=470%2C470%2Cx26%2Cy0%2Csafe&width=146&height=146)
Nicole Lawrance
PhD Student (1st Year). Nicole is working on automated radiometal chemistry to improve the translational pathway of immunoPET conjugates for clinical use in the UK.
![](https://primary.jwwb.nl/public/y/g/q/temp-wibtyspuysxvsaokmyjj/y7f1a4/c26bbebf-0984-4103-bda9-9d38fc9f4dd1png.png?enable-io=true&enable=upscale&crop=1200%2C1200%2Cx0%2Cy200%2Csafe&width=146&height=146)
Cameron Newbould
PhD Student (1st Year). Cameron is working on a novel theranostic platform which aims to expedite the synthesis of next-generation radiopharmaceuticals.
Past Members
![](https://primary.jwwb.nl/public/y/g/q/temp-wibtyspuysxvsaokmyjj/lt33ju/dc2bc385-b498-4b1e-ae5c-f8ef86251a75.jpg?enable-io=true&enable=upscale&crop=810%2C810%2Cx0%2Cy76%2Csafe&width=149&height=149)
Dr Zixuan Yang
Zixuan (Noble) worked on a collaborative project between the Allott and Aboagye group developing new targeted therapeutics for cancer. She was based at Imperial College London. (Co-supervision with Prof Eric Aboagye, Imperial College London)
Viva passed: Jun 2024